The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail

Lacosamide UCB

150 milligram(s) Film-coated tablet

UCB Pharma S.A.EU/1/19/1383/016-021

Main Information

Trade NameLacosamide UCB
Active SubstancesLacosamide
Strength150 milligram(s)
Dosage FormFilm-coated tablet
Licence HolderUCB Pharma S.A.
Licence NumberEU/1/19/1383/016-021

Group Information

ATC CodeN03AX18 lacosamide


Licence Issued26/08/2019
Legal statusProduct subject to prescription which may be renewed (B)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusUnknown


Summary of Product CharacteristicsSearch EMA website
Package LeafletSearch EMA website
Public Assessment ReportSearch EMA website
« Back